Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...

approval in Australia to initiate a first-in-human phase I therapeutic study of 177Lu-labelled RAD-202 (177Lu-RAD-202) for the treatment of HER2-expressing solid tumors, including breast and gastric ...

In an unprecedented move, America is spearheading the largest mobilization in history with a staggering investment of $75 billion dedicated to developing a robust hydrogen infrastructure. This effort ...

With compelling electrophysiological and behavioural evidence, this work establishes that the activity of insulin-producing cells (IPCs) depends on the nutritional state in Drosophila and that, like ...

Steven Farram does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

In a separate announcement, Gilead’s Trodelvy received breakthrough therapy designation from the US Food and Drug Administration (FDA) for treating adults with extensive-stage small cell lung cancer ...

AmericanHort is accepting applications for students to join its HortScholars program at Cultivate'25. HortScholars get the chance to network with industry leaders, give a 5-minute presentation on a ...

Another innovative approach involves using transgenic mice engineered to produce human ... for the generation of fully human antibodies for a range of therapeutic applications.

Polymyxin B Ointment, a compound renowned for its antibacterial qualities, has the potential to provide therapeutic advantages by promoting ... of the Declaration of Helsinki for research involving ...